Skip to main content
Top
Published in: Acta Diabetologica 3/2016

01-06-2016 | Original Article

Triglycerides-to-HDL cholesterol ratio as screening tool for impaired glucose tolerance in obese children and adolescents

Authors: Melania Manco, Graziano Grugni, Mario Di Pietro, Antonio Balsamo, Stefania Di Candia, Giuseppe Stefano Morino, Adriana Franzese, Procolo Di Bonito, Claudio Maffeis, Giuliana Valerio

Published in: Acta Diabetologica | Issue 3/2016

Login to get access

Abstract

Aims

To identify metabolic phenotypes at increased risk of impaired glucose tolerance (IGT) in Italian overweight/obese children (n = 148, age 5–10 years) and adolescents (n = 531, age 10–17.9 year).

Methods

Phenotypes were defined as follows: obesity by the 95th cut-points of the Center for Disease Control body mass index reference standards, impaired fasting glucose (fasting plasma glucose ≥100 mg/dl), high circulating triglycerides (TG), TG/HDL cholesterol ≥2.2, waist-to-height ratio (WTHR) >0.6, and combination of the latter with high TG or TG/HDL cholesterol ≥2.2.

Results

In the 148 obese children, TG/HDL-C ≥ 2.2 (OR 20.19; 95 % CI 2.50–163.28, p = 0.005) and the combination of TG/HDL-C ≥ 2.2 and WTHR > 0.60 (OR 14.97; 95 % CI 2.18–102.76, p = 0.006) were significantly associated with IGT. In the 531 adolescents, TG/HDL-C ≥ 2.2 (OR 1.991; 95 % CI 1.243–3.191, p = 0.004) and the combination with WTHR > 0.60 (OR 2.24; 95 % CI 1.29–3.87, p = 0.004) were associated with significantly increased risk of IGT. In the whole sample, having high TG levels according to the NIH National Heart, Lung and Blood Institute Expert Panel was not associated with an increased risk of presenting IGT.

Conclusions

TG/HDL-C ratio can be useful, particularly in children, to identify obese young patients at risk of IGT. Its accuracy as screening tool in a general population needs to be verified. The combination of TG/HDL-C ratio and WTHR > 0.6 did not improve prediction. Having high TG according to the NIH definition was not associated with increased risk of developing IGT.
Appendix
Available only for authorised users
Literature
1.
go back to reference Misra A, Bhardwaj S (2014) Obesity and the metabolic syndrome in developing countries: focus on South Asians. Nestle Nutr Inst Workshop Ser 78:133–140CrossRefPubMed Misra A, Bhardwaj S (2014) Obesity and the metabolic syndrome in developing countries: focus on South Asians. Nestle Nutr Inst Workshop Ser 78:133–140CrossRefPubMed
2.
go back to reference Savoye M, Caprio S, Dziura J et al (2014) Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial. Diabetes Care 37(2):317–324CrossRefPubMedPubMedCentral Savoye M, Caprio S, Dziura J et al (2014) Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial. Diabetes Care 37(2):317–324CrossRefPubMedPubMedCentral
3.
go back to reference Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2014) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383(9922):1084–1094CrossRefPubMed Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2014) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383(9922):1084–1094CrossRefPubMed
4.
go back to reference Defronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4):773–795CrossRefPubMedPubMedCentral Defronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4):773–795CrossRefPubMedPubMedCentral
6.
go back to reference American Diabetes Association (2004) Screening for type 2 diabetes. Diabetes Care 27:S11–S14CrossRef American Diabetes Association (2004) Screening for type 2 diabetes. Diabetes Care 27:S11–S14CrossRef
7.
go back to reference Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374CrossRefPubMed Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374CrossRefPubMed
8.
go back to reference Cambuli VM, Incani M, Pilia S et al (2009) Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes. Diabetes Metab Res Rev 25:528–534CrossRefPubMed Cambuli VM, Incani M, Pilia S et al (2009) Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes. Diabetes Metab Res Rev 25:528–534CrossRefPubMed
9.
go back to reference Conwell LS, Batch JA (2004) Oral glucose tolerance test in children and adolescents: positives and pitfalls. J Paediatr Child Health 40:620–626CrossRefPubMed Conwell LS, Batch JA (2004) Oral glucose tolerance test in children and adolescents: positives and pitfalls. J Paediatr Child Health 40:620–626CrossRefPubMed
10.
go back to reference Greig F (2012) Which obese youth are at increased risk for type 2 diabetes? Latent class analysis and comparison with diabetic youth. Pediatr Diabetes 13:181–188CrossRefPubMed Greig F (2012) Which obese youth are at increased risk for type 2 diabetes? Latent class analysis and comparison with diabetic youth. Pediatr Diabetes 13:181–188CrossRefPubMed
11.
go back to reference Love-Osborne K, Butler N, Gao D, Zeitler P (2006) Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatr Diabetes 7:205–210CrossRefPubMed Love-Osborne K, Butler N, Gao D, Zeitler P (2006) Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatr Diabetes 7:205–210CrossRefPubMed
12.
go back to reference Tsay J, Pomeranz C, Hassoun A et al (2010) Screening markers of impaired glucose tolerance in the obese pediatric population. Horm Res Paediatr 73:102–107CrossRefPubMed Tsay J, Pomeranz C, Hassoun A et al (2010) Screening markers of impaired glucose tolerance in the obese pediatric population. Horm Res Paediatr 73:102–107CrossRefPubMed
13.
go back to reference Morandi A, Maschio M, Marigliano M et al (2014) Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study. Pediatr Obes 9(1):17–25CrossRefPubMed Morandi A, Maschio M, Marigliano M et al (2014) Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study. Pediatr Obes 9(1):17–25CrossRefPubMed
14.
go back to reference Janghorbani M, Almasi SZ, Amini M (2015) The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction. Acta Diabetol 52(4):781–788CrossRefPubMed Janghorbani M, Almasi SZ, Amini M (2015) The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction. Acta Diabetol 52(4):781–788CrossRefPubMed
15.
go back to reference Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ (2012) Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26). Diabetes Care 35(3):536–541CrossRefPubMedPubMedCentral Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ (2012) Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26). Diabetes Care 35(3):536–541CrossRefPubMedPubMedCentral
16.
go back to reference Ong KK, Petry CJ, Emmett PM et al (2004) Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47(6):1064–1070CrossRefPubMed Ong KK, Petry CJ, Emmett PM et al (2004) Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47(6):1064–1070CrossRefPubMed
17.
18.
go back to reference Valerio G, Maffeis C, Balsamo A et al (2013) Severe obesity and cardiometabolic risk in children: comparison from two international classification systems. PLoS ONE 8(12):e83793CrossRefPubMedPubMedCentral Valerio G, Maffeis C, Balsamo A et al (2013) Severe obesity and cardiometabolic risk in children: comparison from two international classification systems. PLoS ONE 8(12):e83793CrossRefPubMedPubMedCentral
19.
go back to reference National Heart, Lung, and Blood Institute (2011) Expert Panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(suppl 5):S237 National Heart, Lung, and Blood Institute (2011) Expert Panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(suppl 5):S237
20.
go back to reference Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11(246):1–190 Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11(246):1–190
21.
go back to reference Khoury M, Manlhiot C, McCrindle B (2013) Role of the waist/height ratio in the cardiometabolic risk assessment of children classified by body mass index. J Am Coll Cardiol 62:742–751CrossRefPubMed Khoury M, Manlhiot C, McCrindle B (2013) Role of the waist/height ratio in the cardiometabolic risk assessment of children classified by body mass index. J Am Coll Cardiol 62:742–751CrossRefPubMed
22.
go back to reference Di Bonito P, Moio N, Scilla C et al (2012) Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care 35:158–162CrossRefPubMedPubMedCentral Di Bonito P, Moio N, Scilla C et al (2012) Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care 35:158–162CrossRefPubMedPubMedCentral
23.
go back to reference Di Bonito P, Valerio G, Grugni G et al (2015) Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study. Nutr Metab Cardiovasc Dis 25(5):489–494CrossRefPubMed Di Bonito P, Valerio G, Grugni G et al (2015) Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study. Nutr Metab Cardiovasc Dis 25(5):489–494CrossRefPubMed
24.
go back to reference Nolfe G, Spreghini MR, Sforza RW, Morino G, Manco M (2012) Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth. Eur J Endocrinol 166(1):107–114CrossRefPubMed Nolfe G, Spreghini MR, Sforza RW, Morino G, Manco M (2012) Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth. Eur J Endocrinol 166(1):107–114CrossRefPubMed
25.
go back to reference Dabelea D, Mayer-Davis EJ, Saydah S et al (2014) Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311(17):1778–1786CrossRefPubMedPubMedCentral Dabelea D, Mayer-Davis EJ, Saydah S et al (2014) Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311(17):1778–1786CrossRefPubMedPubMedCentral
26.
go back to reference Bonnefond A, Froguel P (2015) Rare and common genetic events in type 2 diabetes: What should biologists know? Cell Metab 21(3):357–368CrossRefPubMed Bonnefond A, Froguel P (2015) Rare and common genetic events in type 2 diabetes: What should biologists know? Cell Metab 21(3):357–368CrossRefPubMed
27.
go back to reference Tanamas SK, Magliano DJ, Balkau B et al (2015) The performance of diabetes risk prediction models in new populations: the role of ethnicity of the development cohort. Acta Diabetol 52(1):91–101CrossRefPubMed Tanamas SK, Magliano DJ, Balkau B et al (2015) The performance of diabetes risk prediction models in new populations: the role of ethnicity of the development cohort. Acta Diabetol 52(1):91–101CrossRefPubMed
28.
go back to reference Giannini C, Santoro N, Caprio S et al (2011) The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 34(8):1869–1874CrossRefPubMedPubMedCentral Giannini C, Santoro N, Caprio S et al (2011) The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 34(8):1869–1874CrossRefPubMedPubMedCentral
29.
go back to reference Maffeis C, Pinelli L, Brambilla P et al (2010) Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity (Silver Spring) 18(7):1437–1442CrossRef Maffeis C, Pinelli L, Brambilla P et al (2010) Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity (Silver Spring) 18(7):1437–1442CrossRef
30.
go back to reference O’Malley G, Santoro N, Northrup V et al (2010) High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation. Diabetologia 53(6):1199–1209CrossRefPubMed O’Malley G, Santoro N, Northrup V et al (2010) High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation. Diabetologia 53(6):1199–1209CrossRefPubMed
31.
go back to reference Morrison KM, Xu L, Tarnopolsky M, Yusuf Z, Atkinson SA, Yusuf S (2012) Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 35(4):711–716CrossRefPubMedPubMedCentral Morrison KM, Xu L, Tarnopolsky M, Yusuf Z, Atkinson SA, Yusuf S (2012) Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 35(4):711–716CrossRefPubMedPubMedCentral
32.
go back to reference Toledo-Corral CM, Alderete TL, Richey J, Sequeira P, Goran MI, Weigensberg MJ (2015) Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents. Acta Diabetol 52(2):277–284CrossRefPubMedPubMedCentral Toledo-Corral CM, Alderete TL, Richey J, Sequeira P, Goran MI, Weigensberg MJ (2015) Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents. Acta Diabetol 52(2):277–284CrossRefPubMedPubMedCentral
33.
go back to reference Bailey DP, Savory LA, Denton SJ, Davies BR, Kerr CJ (2013) The hypertriglyceridemic waist, waist-to-height ratio, and cardiometabolic risk. J Pediatr 162(4):746–752CrossRefPubMed Bailey DP, Savory LA, Denton SJ, Davies BR, Kerr CJ (2013) The hypertriglyceridemic waist, waist-to-height ratio, and cardiometabolic risk. J Pediatr 162(4):746–752CrossRefPubMed
34.
go back to reference Lemieux I, Pascot A, Couillard C et al (2000) Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102(2):179–184CrossRefPubMed Lemieux I, Pascot A, Couillard C et al (2000) Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102(2):179–184CrossRefPubMed
Metadata
Title
Triglycerides-to-HDL cholesterol ratio as screening tool for impaired glucose tolerance in obese children and adolescents
Authors
Melania Manco
Graziano Grugni
Mario Di Pietro
Antonio Balsamo
Stefania Di Candia
Giuseppe Stefano Morino
Adriana Franzese
Procolo Di Bonito
Claudio Maffeis
Giuliana Valerio
Publication date
01-06-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-015-0824-y

Other articles of this Issue 3/2016

Acta Diabetologica 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.